Indaptus Therapeutics, Inc.

NASDAQ:INDP

Biotechnology

Healthcare
$3.29 -2.21%

-$0.03 today

Market cap
$372.57M
Beta
1.14
P/E (TTM)
-0.2
EPS (TTM)
-$8.70
52W Low $0.92High $8.69

Volume 0.17M

Average 0.97M

INDP Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Indaptus Therapeutics, Inc.NASDAQ: INDP

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares declines year over year

Q1 FY2026 weighted avg shares of 2.17M shares fell 76.8% year over year, behind the -56.9% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -51.1% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -76.8% toward the trailing-twelve-month pace of -56.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
2.17M+0.0% QoQ
Last fiscal yearDec 2025
966.12K-89.7% YoY
LTMMar 2026
3.96M-56.9% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-76.8%——
1 year-89.7%——
3-year CAGR-51.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
966.12K USD
Year-over-year change
-89.7%
4-year CAGR
-30.3%

Weighted Avg Shares vs competitors

How INDP compares with its peers on the latest reported figures

  • INDP's LTM Mar 2026 weighted avg shares of 3.96M shares is the lowest of the 2 companies compared; the peer median is 12.42M shares.
  • Its year-over-year change of -56.9% is the lowest of 2, against a peer median of +671.4%.
  • Over three fiscal years its annual growth of -51.1% compares with a peer median of +331.9%.
INDP Competitors Peer median
Weighted Avg Shares for INDP and competitors
Company Period LTM YoY 3-year CAGR
AZTRAzitra, Inc.LTM Jun 202612.42M +671.4%+331.9%
INDPIndaptus Therapeutics, Inc.LTM Mar 20263.96M -56.9%-51.1%
Peer median (excluding INDP) 12.42M+671.4%+331.9%

Competitors are the stored peer set for INDP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development2.52M6.32M7.62M7.25M9.34M
Selling, General & Admin5.21M8.59M8.76M8.11M10.49M
Operating Expenses7.73M14.91M16.38M15.37M19.83M
Depreciation & Amortization1.4K1.78K1.28K7350
EBITDA(7.71M)(14.32M)(15.42M)(15.02M)(20.85M)
EBITDA Margin—————
Operating Income(7.73M)(14.91M)(16.38M)(15.37M)(19.83M)
Operating Margin—————
Interest Income17.72K588.11K000
Interest Expense00000
Other Income / Expenses17.72K588.11K955K343.72K(1.02M)
Income Before Tax(7.71M)(14.32M)(15.42M)(15.02M)(20.85M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(7.71M)(14.32M)(15.42M)(15.02M)(20.85M)
Net Margin—————
EPS (Basic)(1.89)(1.73)(1.84)(1.61)(21.58)
EPS (Diluted)(1.89)(1.73)(1.84)(1.61)(21.58)
Weighted Avg Shares4.09M8.26M8.4M9.36M966.12K
Weighted Avg Shares (Diluted)4.09M8.26M8.4M9.36M966.12K

Indaptus Therapeutics, Inc.

NASDAQ:INDP

Intrinsic Alpha fair value

Locked

Current Price

$3.29

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.